MilliporeSigma to Expand Operations in Gillingham, UK

Jul 02, 2018 Company to expand distribution centre for Life Science products to support future business growth MilliporeSigma, a leading science and technology company, today announced plans to expand its Gillingham, UK distribution centre. The €9 million investment will boost distribution capabilities for the business. Anticipated to open in early 2019, the new facility will... Read more

Tongji University Joins MilliporeSigma’s CRISPR Core Partnership Program

With membership, Tongji University to get exclusive access to MilliporeSigma’s genome-editing technology, comprehensive technical support University joins a network of 70 CRISPR core labs around the world MilliporeSigma, a leading science and technology company and leader in genome editing, today announced a new CRISPR core partnership with Tongji University in Shanghai. Tongji University is the... Read more

MilliporeSigma Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology

News Release June 19, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma to distribute cell line reference materials in U.S. and other select geographies Reference products available in cost-effective, easy-fit blocks for laboratory workflows Products to be available through e-commerce platform, SigmaAldrich.com Burlington, Massachusetts, June 19, 2018 — MilliporeSigma today announced that it has... Read more

Merck KGaA, Darmstadt, Germany Completes Third and Final Registration Phase under the European Chemicals Regulation REACH

June 6, 2018 Your Contact: Gangolf Schrimpf +49 6151 72-9591 Merck KGaA, Darmstadt, Germany Completes Third and Final Registration Phase under the European Chemicals Regulation REACH More than 1,000 registration dossiers successfully submitted for safe use Darmstadt, Germany, June 6, 2018 — Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it... Read more

MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization

News Release June 5, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization Opens North America’s first BioReliance® End-to-End Biodevelopment Center to help customers with biopharmaceutical manufacturing processes Accelerates clinical development from DNA to market “Advance Biotech Grant Program” expands global biotech commitment to help... Read more

MilliporeSigma Announces Collaboration with Solvias for New Pyrogen Detection Kit

News Release May 17, 2018 Your Contact: Karen Tiano +1 978 495 0093 Only cell-line-based Monocyte Activation Test (MAT) kit on the market Detects broad spectrum of pyrogens and offers high reproducibility, sensitivity Eliminates the need for live animal testing Burlington, Massachusetts, May 17, 2018 — MilliporeSigma today announced a collaboration with Solvias, a Swiss contract... Read more

MilliporeSigma to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

News Release May 16, 2018 Your Contact: Karen Tiano +1 978 495 0093 Collaboration with Washington University on gut bacteria research could lead to diagnostics, treatment for malnourished children Study to use MilliporeSigma’s genome-editing technology Burlington, Massachusetts, May 16, 2018 — MilliporeSigma, a leader in genome editing, today announced a collaboration with Washington University in St.... Read more

MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection

News Release April 27, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection Highly sensitive optical system based on patented technology unique to MilliporeSigma’s Amnis® flow cytometers Configurable, 7-laser capacity to meet researchers’ evolving needs Laser upgrades quickly performed in lab with no... Read more

MilliporeSigma Receives Patent for CRISPR Technology in China

MilliporeSigma Receives Patent for CRISPR Technology in China Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards Foundational CRISPR patents now granted in seven markets, including Canada and Europe Burlington, Massachusetts, April... Read more

MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Award recognizes new, fully synthetic clarification filter Millistak+® HC Pro portfolio of depth filters improves capacity, reducing footprint by up to 2x for primary clarification Burlington, Massachusetts, April 18, 2018 — MilliporeSigma today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation. “MilliporeSigma is dedicated to delivering innovations that bring... Read more